FDA DENIES Emergency Use For New Covid-19 Drug

Mixed reactions to this one…

The FDA would approve anything that brings money to their basket. They approved Pfizer’s COVID-19 jab without any studies or research on the potential side effects. The vaccine was made in a few months and the FDA says it’s fit for global use.

Join Our Telegram channel here:

Now they have denied emergency clearance for lenziluman. It’s a monoclonal antibody treatment. Why did they do this? No response…

They approved Pfizer, but denied this?

How come?

Joe Rogan announced that the monoclonal antibody treatment has helped him fight COVID-19.

The Epoch Times shared parts from the letter from The FDA:

“In its letter, FDA stated that it was unable to conclude that the known and potential benefits of lenzilumab outweigh the known and potential risks of its use as a treatment for COVID-19,” the Burlingame, California-based firm said in a statement.

The head of Humanigen, Cameron Durrant, said that the company plans to keep trying to develop the drug.

“We believe the ongoing ACTIV-5/BET-B trial, which has been advanced to enroll up to 500 patients, may provide additional safety and efficacy data sufficient to support our efforts to obtain an [emergency use authorization] to treat hospitalized COVID-19 patients,” he said.

Reuters offered more:

Humanigen expects an ongoing study to provide additional safety and efficacy data to support its new EUA request.

The company filed its application with the FDA for emergency use of the drug in May, citing late-stage trial data.

Humanigen also started the process of UK authorization for the drug in June through a rolling review submission.

Join Our Telegram channel here:

Source: WeLoveTrump

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker